Global Oxidative Stress Assays Market to Reach $1.9 Billion by 2030
The global market for Oxidative Stress Assays estimated at US$971.6 Million in the year 2022, is projected to reach a revised size of US$1.9 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 9.3% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 7.2% CAGR for the next 8-year period.The U.S. Market is Estimated at $288.8 Million, While China is Forecast to Grow at 7.8% CAGR
The Oxidative Stress Assays market in the U.S. is estimated at US$288.8 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$317.7 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.6% and 7.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.Select Competitors (Total 11 Featured) -
- Abcam PLC
- AMS Biotechnology (Europe) Ltd. (AMSBIO)
- Biovision Inc.
- Cell Biolabs, Inc.
- Enzo Biochem, Inc.
- Merck KgaA
- MilliporeSigma
- Oxford Biomedical Research, Inc.
- Promega Corporation
- Qiagen NV
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam PLC
- AMS Biotechnology (Europe) Ltd. (AMSBIO)
- Biovision Inc.
- Cell Biolabs, Inc.
- Enzo Biochem, Inc.
- Merck KgaA
- MilliporeSigma
- Oxford Biomedical Research, Inc.
- Promega Corporation
- Qiagen NV
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 179 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 971.6 Million |
Forecasted Market Value ( USD | $ 1900 Million |
Compound Annual Growth Rate | 8.7% |
Regions Covered | Global |